News Release Ryder Reports Third Quarter 2024 Results Delivers Solid Q3 Results; Continues to Outperform Prior Cycles Third Quarter 2024 Highlights • GAAP EPS from continuing operations of $3.25 compared to $3.44 in prior year • Comparable EPS (non-GAAP) from continuing operations of $3.44, as compared to $3.58 in prior year, reflecting weaker market conditions in rental and used vehicle sales, partially offset by higher earnings in contractual lease, supply chain, and dedicated businesses • Total revenue o ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Ryder (R) , which belongs to the Zacks Transportation - Equipment and Leasing industry, could be a great candidate to consider.This truck leasing company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 18.13%.For the most recent quarter, Ryder ...

Wall Street analysts forecast that Ryder (R) will report quarterly earnings of $3.39 per share in its upcoming release, pointing to a year-over-year decline of 5.3%. It is anticipated that revenues will amount to $3.37 billion, exhibiting an increase of 15.2% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone an upward revision of 1.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their ini ...

Ryder (R) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on October 24, 2024, might help the stock move higher if these key numbers are better than expect ...

Core Viewpoint - Elite Pharmaceuticals has received marketing approval from the Israeli Ministry of Health for its generic version of Adderall®, which is indicated for the treatment of ADHD and Narcolepsy [2][3]. Company Overview - Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing niche generic products, including immediate-release and controlled-release solid oral dose products [4]. - The company operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ [4]. Product Details - The approved generic Adderall® comes in strengths of 10 mg, 20 mg, and 30 mg tablets and is a central nervous system stimulant [2]. - The product will be supplied to Dexcel Pharma, the exclusive distributor for the Israeli market, under a License and Distribution Agreement [3]. Distribution Agreement - Under the agreement, Elite will manufacture and package the product, while Dexcel will handle sales, marketing, and distribution at its own expense [3]. - Dexcel will pay an agreed transfer price for the product and share profits under certain conditions [3].

Ryder System (R) has displayed an impressive performance, with its shares appreciating 20.3% over the past six months. This growth is impressive and has outperformed its industry. Additionally, Ryder's price performance compares favorably with that of other companies in the Equipment and Leasing industry like Wabtec Corporation (WAB) and Air Lease Corporation (AL) . Six-Month Price Performance Given the recent rally, the question that naturally arises is whether Ryder stock can sustain its bullish price per ...

Shares of Ryder System (R) scaled a 52-week high of $143.73 in the trading session on Aug. 26, 2024, before closing a tad lower at $141.25. The company's shares have gained 25.2% over the past six months, steadily outperforming the 16.4% rise of the industry it belongs to. Image Source: Zacks Investment Research Why the Uptick in the Ryder Stock? Ryder's bottom line has been benefitting from its consistent efforts to reward its shareholders through dividends and share buybacks are appreciative. In 2022, Ryd ...

Core Insights - Therma Bright Inc. announces a significant milestone with its portfolio company Inretio, as Inretio's Preva® ischemic stroke clot removal device successfully completes its third human trial, indicating its potential to transform stroke and blood clot treatment [2][3][7] Company Overview - Therma Bright Inc. is a developer and investment partner in advanced diagnostic and medical device technologies, focusing on innovative solutions for critical healthcare challenges [8] Product Innovation - The Preva® device represents a major advancement in thrombectomy procedures, designed to restore blood flow in ischemic stroke patients effectively, even when traditional treatments fail [3][4] - The device utilizes a patented solution that minimizes the risk of embolization and reduces the need for repeated maneuvers during the procedure [4] Market Potential - The global coronary stents market is projected to exceed USD 4.8 billion by 2029, presenting a growth opportunity for Inretio's Preva® solution and Therma Bright's investment [6] - The demand for advanced clot removal solutions is increasing, positioning Therma Bright's investment in Inretio to potentially yield significant returns as the technology progresses [7]

Ryder System's (R) top line is boosted by a robust segmental performance by Dedicated Transportation Solutions ("DTS") and Supply Chain Solutions ("SCS"). Proactive cost-cutting efforts and a shareholderfriendly approach bode well for the company. However, R is grappling with soft freight market conditions. Factors Favoring R Ryder's top line is bolstered by its strong segmental performance. As a reflection of this, in the second quarter of 2024, the Fleet Management Solutions ("FMS") unit saw a 2% revenue ...

Ryder System, Inc. (NYSE:R) Q2 2024 Results Conference Call July 25, 2024 11:00 AM ET Company Participants Calene Candela - Vice President-Investor Relations Robert Sanchez - Chairman and Chief Executive Officer John Diez - Executive Vice President and Chief Financial Officer Tom Havens - President of Global Fleet Management Solutions Steve Sensing - President-Global Supply Chain Solutions and Dedicated Transportation Conference Call Participants Christyne McGarvey - Morgan Stanley Jeff Kauffman - Vertical ...